Jan 22, 2015 Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences Fluorescence Cancer-Targeting Agents Chosen for the Cover of Neurosurgery Learn More
Dec 4, 2014 Cellectar Biosciences Granted Orphan Designation for I-131-CLR1404 for the Treatment of Multiple Myeloma Learn More
Nov 25, 2014 Cellectar Biosciences Names Cameron Szakacs, Ph.D. Vice President of Clinical Development Learn More